ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry (SABLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01729455
Recruitment Status : Recruiting
First Posted : November 20, 2012
Last Update Posted : July 16, 2018
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 31, 2025
  Estimated Study Completion Date : January 31, 2025